We are proud to announce Kriba’s participation in the IX Annual Congress of the Spanish Society of Ocular Inflammation (SEIOC). The congress will be held on November 16th and 17th at the Ramón y Cajal Hospital in Madrid.
María Calatayud Riera, a resident in the Ophthalmology Department of the Germans Trías i Pujol Hospital in Badalona (Barcelona), will present the first results of the project, selected for an oral presentation.
The results correspond to Phase I of the clinical trial for the validation of our device, Neosonics, in its application for the early detection and objective monitoring of the response to treatment of anterior uveitis.
This first proof-of-concept phase has been conducted in collaboration with the Germans Trias i Pujol University Hospital with the contribution of Dr. J. Ramon Anglada and his team.
Phase II of the trial, focused on efficacy, is scheduled to be initiated throughout 2024. More details on this phase will be announced soon.
The abstract submitted for the congress, entitled “Preliminary Results of a New Automatic Cellularity Detection System Using High-Resolution Ultrasound and Deep Learning in Anterior Uveitis,” has been accepted as an oral presentation in the session on Thursday, November 16, which will take place from 09:00 to 10:40 under the category “Free Presentations I.”
Kriba, in its Eye Care area, is dedicated to the development of solutions for non-invasive early detection and quantitative monitoring of uveitis, an associated clinical condition that, if treated late or inaccurately, can lead to up to 70% vision loss and up to 20% blindness. Despite being a rare and little-known disease, uveitis is the third leading cause of blindness in high-income countries.
Neosonics, our investigational device, is a non-invasive, automated white blood cell counter powered by artificial intelligence and deep learning algorithms. It provides an accurate and objective approach to the detection and monitoring of uveitis, all with the eyelid closed, in a matter of seconds and with minimal interaction from the medical professional.
The SEIOC is a non-profit association dedicated to the dissemination, study, and research of Ocular Inflammatory Diseases. The SEIOC focuses on promoting the knowledge of these diseases, fostering multidisciplinarity in their diagnosis and treatment, and stimulating the quality of care and uniformity of criteria for their evaluation.